IL327478A - D מעכבי dclk1 ושיטות לטיפול - Google Patents

D מעכבי dclk1 ושיטות לטיפול

Info

Publication number
IL327478A
IL327478A IL327478A IL32747826A IL327478A IL 327478 A IL327478 A IL 327478A IL 327478 A IL327478 A IL 327478A IL 32747826 A IL32747826 A IL 32747826A IL 327478 A IL327478 A IL 327478A
Authority
IL
Israel
Prior art keywords
cancer
dclk1
inhibitor compound
pct
oil
Prior art date
Application number
IL327478A
Other languages
English (en)
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Publication of IL327478A publication Critical patent/IL327478A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL327478A 2023-10-02 2024-10-02 D מעכבי dclk1 ושיטות לטיפול IL327478A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363587362P 2023-10-02 2023-10-02
PCT/US2024/049605 WO2025076093A1 (en) 2023-10-02 2024-10-02 Dclk1 inhibitors and methods of treatment

Publications (1)

Publication Number Publication Date
IL327478A true IL327478A (he) 2026-05-01

Family

ID=95284159

Family Applications (1)

Application Number Title Priority Date Filing Date
IL327478A IL327478A (he) 2023-10-02 2024-10-02 D מעכבי dclk1 ושיטות לטיפול

Country Status (5)

Country Link
EP (1) EP4788329A1 (he)
CN (1) CN122161595A (he)
AU (1) AU2024355086A1 (he)
IL (1) IL327478A (he)
WO (1) WO2025076093A1 (he)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518312A (ja) * 2014-06-05 2017-07-06 ユニバーシティ・オブ・カンザス マルメリン類似体および癌治療における使用方法

Also Published As

Publication number Publication date
EP4788329A1 (en) 2026-08-12
CN122161595A (zh) 2026-06-05
AU2024355086A1 (en) 2026-05-14
WO2025076093A1 (en) 2025-04-10

Similar Documents

Publication Publication Date Title
IL320388A (he) מעכבי kras מקרוציקליים ושיטות שימוש
IL297625B2 (he) מעכבי pi3k-אלפא ושיטות לשימוש בהם
IL321357A (he) מעכבי kif18a ושימושים שלהם
IL318169A (he) מעכבי Apol1 ושיטות שימוש זהות
IL319748A (he) מעכבי pcsk9 ושיטות לשימוש בהם
IL316619A (he) מעכבי pi3kα ושיטות לשימוש בהם
IL312348A (he) מעכבי hif-2alpha ושיטות השימוש בו
IL310812A (he) צורות מוצקות של מעכבי apol1 spirotricyclic ושיטות שימושן
IL314320A (he) תרכובות ושיטות לשימוש
IL320848A (he) מעכבי ripk2 ושימושים רפואיים בהם
IL315503A (he) שיטות לטיפול
IL318393A (he) תרכובות אזא-קווינאזולין ושיטות לשימוש
IL320711A (he) שיטות טיפול
IL317288A (he) מעכבי ביטוי ו/או תפקוד
IL314277A (he) תרכובות אנטי- b7-h3 ושיטות לשימוש
GB202201824D0 (en) Methods of treatment
IL327384A (he) מעכבי cbl-b ושיטות לשימוש בהם
AU2024355086A1 (en) Dclk1 inhibitors and methods of treatment
GB202317431D0 (en) Arrangement and method for treatment of fish
GB2607584B (en) Composition and method of treatment
GB202201819D0 (en) Methods of treatment
GB202201825D0 (en) Methods of treatment
EP4117622B1 (en) NEW USE AND NEW PROCESSING METHOD
IL317043A (he) מעכבים של ripk1 ושיטות לשימוש
AU2021902069A0 (en) Methods of treatment and inhibition